Innovation

5 patent families (4 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 284 times.

Year	Filings
2016	1
2017	2
2018	5
2019	2
2020	1
2021	1
2022	1

Investor mix

2 investors on record; lead investors include Doool Industrial, Shenzhen Hepalink Pharmaceutical.

Investor type	Count	Share
Other / undisclosed	2	100%